Urinary Tract Infection
The most common bacterial infection in women — and the one with the most bad advice attached
What it is
A urinary tract infection is a bacterial infection of the bladder and urethra, usually caused by E. coli travelling from the bowel. In its ordinary form — lower UTI, or cystitis — it causes burning on passing urine, needing to go frequently and urgently, and lower abdominal discomfort. It is extremely common in women and uncommon in men, and in an otherwise healthy non-pregnant woman it is usually a self-limiting nuisance rather than a dangerous illness. It becomes serious when it moves upward to the kidneys.
Why it matters
Around half of women will have at least one UTI in their lifetime, and a substantial minority get them repeatedly — a genuinely miserable, life-shaping problem that is often dismissed. It matters for a second reason too: UTIs are one of the largest single drivers of antibiotic prescribing in primary care, and antibiotic use measurably raises the chance that the next infection is resistant. Getting this right is both a personal and a public health question, and the advice people are given is unusually poor.
What BioSignal knows about treating this
What works for Urinary Tract Infection
BioSignal’s clinical summary, most important first.
- A short course of an appropriate antibiotic — the mainstay for symptomatic infection
- A back-up ('delayed') antibiotic prescription in non-pregnant women, to use only if symptoms do not settle
- Vaginal oestrogen for recurrent UTI after the menopause
- Methenamine hippurate as an antibiotic-sparing option for recurrent UTI
- Cranberry products for prevention of recurrent UTI in women
- Increased fluid intake — but only if you currently drink less than about 1.5 litres a day
Signal Records relevant to this condition
Interventions and contributing factors — some of these records describe a cause rather than a cure. The rating shown is BioSignal’s confidence in that Signal Record, not a claim about how well it treats this condition. Open any of them for the full evidence.
- NSAIDsHigh confidence
They work for osteoarthritis. The harms are real, dose-dependent, and different for every drug — and the cardiovascular and gastrointestinal risks rank in opposite directions, so there is no safe NSAID. Paracetamol is not the safe alternative; it barely works for these conditions.
- ProbioticsLimited evidence
Specific strains help specific conditions. 'Probiotics for gut health' in healthy adults is not supported — fibre has the better evidence.
New to this? Read these first
How this usually unfolds
- Recognize risk factors
- Get diagnosed
- Track key biomarkers
- Lifestyle first
- Evidence-based treatment
- Long-term monitoring
Who is at risk
- Being female — a shorter urethra, and the main risk factor there is
- Sexual activity
- Menopause — falling oestrogen changes the vaginal and urinary environment
- A previous UTI (the strongest predictor of the next one)
- Incomplete bladder emptying
- Diabetes
- Urinary catheters
- Spermicide use
How it's diagnosed
In a non-pregnant woman with classic symptoms — burning, frequency, urgency — the diagnosis is usually clinical, and a urine dipstick adds little. A urine culture is recommended when the diagnosis is uncertain, when symptoms recur, when treatment fails, and always in men, in pregnancy, and in children. Importantly, bacteria found in the urine of someone with NO symptoms (asymptomatic bacteriuria) should not be treated, with the single exception of pregnancy — treating it otherwise breeds resistance without helping anyone.
Key biomarkers
Lifestyle
Explore this condition across BioSignal
Related Foundations
Related Signal Records
Related body systems
Related conditions
Frequently asked questions
Does cranberry actually work, or is that a myth?
It works — and the confident debunking you have read is out of date. The most recent Cochrane review, covering 50 studies and 8,857 participants, found that cranberry products reduce the risk of symptomatic, culture-confirmed UTIs, with moderate certainty (a roughly 30% relative reduction overall, and about 26% in women with recurrent UTIs). In 2025 the American Urological Association upgraded its position from 'may offer' to clinicians SHOULD offer cranberry as a prevention option. Two honest caveats: it does not work in everyone — there is no benefit in elderly institutionalised people, in pregnancy, or in people with neurogenic bladders — and it is a PREVENTION strategy, not a treatment for an infection you already have.
What about D-mannose? Everyone says it's better than cranberry.
It failed. In 2024 a double-blind randomised trial across 99 UK primary care centres gave 598 women with recurrent UTI either D-mannose or placebo for six months. The rate of medically attended UTI was 51.0% on D-mannose and 55.7% on placebo — a difference of 5 percentage points with a confidence interval spanning zero (p = 0.26). No secondary outcome favoured it either. The authors' conclusion was blunt: D-mannose should not be recommended for prophylaxis in this group. This is a striking result, because D-mannose is the supplement that largely displaced cranberry in the wellness aisle — and the evidence points the opposite way.
Can I just take ibuprofen and avoid antibiotics?
Please don't, and this is the one piece of advice on this page that could genuinely hurt you. It is true that more than half of uncomplicated UTIs settle without antibiotics, and that is tempting. But when this was tested — 181 women given ibuprofen instead of an antibiotic — seven of them developed a kidney infection and five were hospitalised. Not one woman in the antibiotic group did. A Cochrane review reached the same place: NSAIDs give less symptom resolution and triple the need for rescue antibiotics. The antibiotic-sparing approach that IS supported is a back-up prescription — a script you hold and only fill if things do not settle within 48 hours — not a painkiller instead.
I keep getting UTIs since the menopause. Why?
Because falling oestrogen changes the vaginal and urinary environment — the protective lactobacilli disappear and the pH rises. This is a hormonal problem, and it has a hormonal answer: vaginal oestrogen. In the landmark trial, UTI episodes fell from 5.9 per patient-year on placebo to 0.5 on intravaginal oestriol, and major guidelines now recommend it. Note the specific form: VAGINAL oestrogen works; ORAL oestrogen does not (pooled relative risk 1.08 — no benefit), and systemic HRT is not recommended for this purpose.
Should I drink more water?
Only if you currently drink very little. The trial that supports this recruited women who were drinking under 1.5 litres a day and asked them to add 1.5 litres more; their UTI episodes fell from 3.2 to 1.7 a year. That is a real effect. But two caveats belong on the label: the trial was open-label, and it was funded and part-authored by a bottled-water company. And it tells you nothing about whether someone already drinking plenty benefits from drinking more. Guidelines reflect this narrowness — they recommend increased fluids only for people below that threshold.
When is a UTI an emergency?
When it looks like it has reached the kidneys or the bloodstream. Fever above 38°C, chills, pain in the flank or back, nausea and vomiting, or feeling systemically very unwell — with or without the usual burning — suggest a kidney infection, which needs urgent medical assessment and can progress to sepsis. Seek urgent care too if symptoms worsen quickly, if they do not begin improving within 48 hours of starting an antibiotic, if there is blood in the urine, or if you are pregnant, male, or have a catheter. This page is about ordinary lower urinary tract infection; it is not the right page for any of those.
Evidence summary
Uncomplicated lower UTI in non-pregnant women is usually self-limiting, and a back-up antibiotic prescription is an evidence-supported alternative to immediate treatment — it achieves similar symptom control while reducing antibiotic use, at the cost of symptoms lasting longer. Substituting an NSAID for an antibiotic is NOT a safe strategy: a randomised trial found significantly less symptom resolution and an excess of pyelonephritis (7 of 181 women, five hospitalised), and a Cochrane review confirmed both less symptom resolution and a threefold increase in rescue antibiotic use. For prevention of recurrent UTI, the strongest evidence supports vaginal oestrogen in postmenopausal women; methenamine hippurate is non-inferior to daily antibiotic prophylaxis (though non-inferior is not the same as equal — it produced about half an extra UTI per person-year); cranberry products reduce recurrence with moderate certainty; and increased fluid intake helps in women drinking under 1.5 litres a day, on open-label and industry-funded evidence. D-mannose was tested in a 598-woman randomised trial and did not work. Asymptomatic bacteriuria should not be screened for or treated outside pregnancy, and antibiotic exposure measurably increases the odds of resistance in urinary bacteria within the following two months.
References & sources
- Williams G, Stothart CI, Hahn D, et al. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2023;11:CD001321 (PMID 37947276)
- Hayward G, Mort S, Hay AD, et al. D-Mannose for prevention of recurrent urinary tract infection among women: a randomized clinical trial. JAMA Intern Med 2024;184(6):619-628 (PMID 38587819)
- Harding C, Mossop H, Homer T, et al. Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women (ALTAR): multicentre, open label, randomised, non-inferiority trial. BMJ 2022;376:e068229 (PMID 35264408)
- Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993;329(11):753-756 (PMID 8350884)
- Perrotta C, Aznar M, Mejia R, et al. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev 2008;(2):CD005131 (PMID 18425910)
- Hooton TM, Vecchio M, Iroz A, et al. Effect of increased daily water intake in premenopausal women with recurrent urinary tract infections: a randomized clinical trial. JAMA Intern Med 2018;178(11):1509-1515 (PMID 30285042)
- Vik I, Bollestad M, Grude N, et al. Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women — a double-blind, randomized non-inferiority trial. PLoS Med 2018;15(5):e1002569 (PMID 29763434)
- Sachdeva A, Rai BP, Veeratterapillay R, et al. Non-steroidal anti-inflammatory drugs for treating symptomatic uncomplicated urinary tract infections in non-pregnant adult women. Cochrane Database Syst Rev 2024;12:CD014762 (PMID 39698942)
- Little P, Moore MV, Turner S, et al. Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial. BMJ 2010;340:c199 (PMID 20139214)
- Costelloe C, Metcalfe C, Lovering A, et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010 (PMID 20483949)
- Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the IDSA and ESCMID. Clin Infect Dis 2011;52(5):e103-e120 (PMID 21292654)
- NICE NG109 — Urinary tract infection (lower): antimicrobial prescribing (2018)
- NICE NG112 — Urinary tract infection (recurrent): antimicrobial prescribing (2018, updated December 2024)
- EAU Guidelines on Urological Infections (2026 edition)
- Ackerman AL, Bradley M, D'Anci KE, et al. Updates to recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline (2025)
Educational information — not medical advice
Is this condition page clear, accurate, and useful? Your feedback shapes what we review next.
Give feedback